文献速递间质性肺疾病

脂质生物标志物5-HETE用于识别特发性肺纤维化急性加重

The potential lipid biomarker 5-HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis.
PubMed 文献 · Respirology · 2024-12-16

该研究纳入34例对照、37例稳定期IPF和41例急性加重期IPF患者,采用UHPLC-MS/MS分析血清脂质代谢差异。结果发现AE-IPF患者血清5-HETE显著升高,且与疾病严重程度(CT评分、PaO2/FiO2)和生存时间相关,提示5-HETE可能是AE-IPF诊断和预后评估的潜在脂质生物标志物。

要点

  • AE-IPF患者血清5-HETE较稳定期IPF显著升高,内外验证队列一致。
  • 5-HETE与CT评分、PaO2/FiO2及生存时间显著相关。
  • 5-HETE或可作为AE-IPF诊断与预后评估的潜在生物标志物。

核心结论

  • 脂质重编程可能为IPF提供新的治疗思路,5-HETE可能是AE-IPF的潜在生物标志物。

研究设计与样本

  • 研究纳入34例对照、37例稳定期IPF和41例AE-IPF患者,采集血清样本。
  • 采用UHPLC-MS/MS进行脂质组学分析,并用ELISA、qPCR和western blot验证候选标志物。

主要发现

  • 与对照相比,所有IPF患者中鉴定出32种脂质代谢物和5条脂质代谢通路富集。
  • AE-IPF与稳定期IPF比较,鉴定出19种脂质代谢物和12条通路,其中5-HETE在AE-IPF中显著升高。
  • 内部和外部验证队列中,AE-IPF患者血清5-HETE水平均显著高于稳定期IPF。
  • AE-IPF患者肺组织中5-HETE相关脂质代谢通路指标较稳定期IPF显著改变。
  • 血清5-HETE水平与疾病严重程度(CT评分和PaO2/FiO2比值)及生存时间显著相关。

关键数值与推荐

  • ROC曲线、Kaplan-Meier分析和多因素Cox回归分析显示5-HETE对AE-IPF的诊断和预后具有潜在价值。

临床怎么用

  • 血清5-HETE有望辅助识别AE-IPF并评估疾病严重程度与预后,但需进一步验证后用于临床。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Acute exacerbation (AE) is often the fatal complication of idiopathic pulmonary fibrosis (IPF). Emerging evidence indicates that metabolic reprogramming and dysregulation of lipid metabolism are distinctive characteristics of IPF. However, the lipid metabolic mechanisms that underlie the pathophysiology of AE-IPF remain elusive. METHODS: Serum samples for pilot study were collected from 34 Controls, 37 stable IPF (S-IPF) cases and 41 AE-IPF patients. UHPLC-MS/MS was utilized to investigate metabolic variations and identify lipid biomarkers in serum. ELISA, quantitative PCR and western blot were employed to validate the identified biomarkers. RESULTS: There were 32 lipid metabolites and 5 lipid metabolism pathways enriched in all IPF patients compared to Controls. In AE-IPF versus S-IPF, 19 lipid metabolites and 12 pathways were identified, with 5-hydroxyeicosatetraenoic Acid (5-HETE) significantly elevated in AE-IPF. Both in internal and external validation cohorts, the serum levels of 5-HETE were significantly elevated in AE-IPF patients compared to S-IPF subjects. Consequently, the indicators related to 5-HETE in lipid metabolic pathway were significantly changed in AE-IPF patients compared with S-IPF cases in the lung tissues. The serum level of 5-HETE was significantly correlated with the disease severity (CT score and PaO2/FiO2 ratio) and survival time. Importantly, the receiver operating characteristic (ROC) curve, Kaplan-Meier analysis and Multivariate Cox regression analysis demonstrated that 5-HETE represents a promising lipid biomarker for the diagnosis and prognosis of AE-IPF. CONCLUSION: Our study highlights lipid reprogramming as a novel therapeutic approach for IPF, and 5-HETE may be a potential biomarker of AE-IPF patients.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Zhao Y, Shi Y, Zhang J, et al. The potential lipid biomarker 5-HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis. Respirology. 2024. PMID: 39681341. doi:10.1111/resp.14866

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。